Tonix Pharmaceuticals Holding Corp. Logo

Tonix Pharmaceuticals Holding Corp.

Develops therapies and vaccines for complex conditions and public health challenges.

TNXP | US

Overview

Corporate Details

ISIN(s):
US8902608392
LEI:
Country:
United States of America
Address:
26 MAIN STREET, SUITE 101, 7928 CHATHAM
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company that develops therapies and vaccines for complex, chronic conditions and public health challenges. The company's pipeline is focused on four main therapeutic areas: Central Nervous System (CNS) disorders, immunology, infectious diseases, and rare diseases. Key development programs include treatments for acute stress disorder, organ transplant rejection, Prader-Willi syndrome, and various cancers. Tonix also utilizes an in-house live virus vaccine platform to develop biodefense countermeasures against pathogens such as mpox and smallpox. The company's approach is centered on addressing unmet medical needs through scientific development of its portfolio of investigational product candidates.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Tonix Pharmaceuticals Holding Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Tonix Pharmaceuticals Holding Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Tonix Pharmaceuticals Holding Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

biote Corp. Logo
Trains practitioners in hormone optimization using bioidentical pellets and nutraceuticals.
United States of America
BTMD
Biotest AG Logo
Develops plasma protein products & biotherapeutics for immunology, haematology & intensive care.
Germany
BIO3
Biotika A.S. Logo
Biotech firm making penicillin & polymyxin B APIs for human/vet use, plus contract manufacturing.
Slovakia
BSL
Bioton S.A. Logo
Develops and manufactures recombinant human insulin for global diabetes care solutions.
Poland
BIO
BIOVENTIX PLC Logo
Develops high-affinity sheep monoclonal antibodies for global clinical diagnostic immunoassays.
United Kingdom
BVXP
Bioversys N Logo
Develops novel therapeutics to combat antimicrobial resistance in life-threatening infections.
Switzerland
BIOV
Biovica International B Logo
Develops blood tests to monitor the efficacy of solid tumor cancer therapies.
Sweden
BIOVIC
BIOVIE INC. Logo
Develops drug therapies for Alzheimer's, Parkinson's, and advanced liver diseases by targeting inflammation.
United States of America
BIVI
BioXcel Therapeutics, Inc. Logo
AI-driven biopharma developing treatments for neuroscience and immuno-oncology.
United States of America
BTAI
Black Diamond Therapeutics, Inc. Logo
Develops precision oncology drugs targeting mutation families in lung and brain cancers.
United States of America
BDTX

Talk to a Data Expert

Have a question? We'll get back to you promptly.